Journal of Diagnostics Concepts & Practice >
Clinical and pathological analysis of gastrointestinal leiomyosarcoma:Report of three cases
Received date: 2024-04-14
Accepted date: 2024-08-06
Online published: 2025-02-25
This study reports three rare cases of primary leiomyosarcoma (LMS) originating in the gastrointestinal tract. Among the three patients, one was male and two were females, aged 58 to 68 years. The tumors originated in the stomach in two cases and in the small intestine in one case. Histopathological examination of the surgical specimens showed that the tumors exhibited infiltrative growth, all invading the muscularis propria, and mucosal surface ulceration was observed in two cases. The tumor cells were spindle-shaped, arranged in bundles or interwoven patterns. The cytoplasm was abundant and eosinophilic, and the nuclei showed moderate to high atypia, with mitotic figures easily observed (50-100/50 HPF). Immunohistochemical staining revealed that the tumor cells were positive for SMA(3/3), Desmin and Caldesmon(2/3), but negative for CD117, Dog-1, and CD34(3/3). The Ki-67 proliferation index ranged from 30% to 80%. The follow-up periods of the three patients ranged from 11 to 53 months. Two patients were tumor-free, while one patient developed pancreatic metastasis 30 months after surgery but remained alive at the last follow-up at 53 months. LMS is a rare soft tissue sarcoma, and primary gastrointestinal LMS is extremely rare. The definitive diagnosis of the disease is based on postoperative pathological examination. LMS tumor cells are spindle-shaped, with eosinophilic cytoplasm and significant nuclear atypia, expressing smooth muscle cell markers. It is necessary to differentiate from gastrointestinal stromal tumors and other spindle cell tumors. Surgical resection remains the primary treatment, but the prognosis is generally poor, highlighting the importance of accurate diagnosis.
Key words: Leiomyosarcoma; Gastrointestinal tumors; Prognosis; Immunohistochemistry
WANG Yurong , WANG Yuanyuan , WENG Haiyan . Clinical and pathological analysis of gastrointestinal leiomyosarcoma:Report of three cases[J]. Journal of Diagnostics Concepts & Practice, 2024 , 23(05) : 537 -541 . DOI: 10.16150/j.1671-2870.2024.05.011
[1] | SERRANO C, GEORGE S. Leiomyosarcoma[J]. Hematol Oncol Clin North Am, 2013, 27(5):957-974. |
[2] | GEORGE S, SERRANO C, HENSLEY M L, et al. Soft tissue and uterine leiomyosarcoma[J]. J Clin Oncol, 2018, 36(2):144-150. |
[3] | KANG W Z, XUE L Y, TIAN Y T. Leiomyosarcoma of the stomach: A case report[J]. World J Clin Cases, 2019, 7 (21):3575-3582. |
[4] | AGGARWAL G, SHARMA S, ZHENG M, et al. Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era[J]. Ann Diagn Pathol, 2012, 16(6):532-540. |
[5] | TAKAGI T, SAITO S, YOKOTA S, et al. Laparoscopic and endoscopic cooperative surgery for leiomyosarcoma of the stomach: a case report with a review of the literature[J]. Surg Case Rep, 2021, 7(1):146. |
[6] | BANANZADEH A, MOKHTARI M, SOHOOLI M, et al. Two cases of primary leiomyosarcoma of sigmoid colon treated with laparoscopic surgery: A case report and a review of literature[J]. Int J Surg Case Rep, 2021, 87:106420. |
[7] | WANG T, ZREIK R, LENG B. The landscape of primary gastric leiomyosarcoma in texas population: analysis of texas cancer registry data[J]. Cureus, 2023, 15(11):e49403. |
[8] | ANNICCHIARICO A, MONTALI F, BALDINU M, et al. Leiomyosarcoma of the rectum: A systematic review of recent literature[J]. J Surg Oncol, 2024, 129(2):365-380. |
[9] | ARTS R, BOSSCHA K, RANSCHAERT E, et al. Small bowel leiomyosarcoma: a case report and literature review[J]. Turk J Gastroenterol, 2012, 23(4):381-384. |
[10] | MIETTINEN M, LASOTA J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis[J]. Arch Pathol Lab Med, 2006, 130(10):1466-1478. |
[11] | BASU I, LEMONAS P. Leiomyosarcoma of the rectum following pelvic irradiation: a difficult histological diagnosis[J]. Ann R Coll Surg Engl, 2012, 94(1):e44-e45 |
[12] | CRYSTAL J S, KORDERAS K, SCHWARTZBERG D, et al. Primary leiomyosarcoma of the colon: a report of two cases, review of the literature, and association with immunosuppression for IBD and rheumatoid arthritis[J]. Case Rep Surg, 2018, 2018:6824643. |
[13] | MARUZZO M, BRUNELLO A, DIMINUTTO A, et al. Long-term response to first-line trabectedin in an elderly female patient with a metastatic leiomyosarcoma unfit for anthracycline[J]. Anticancer Drugs, 2016, 27(3):264-267. |
[14] | COCO C, RIZZO G, MANNO A, et al. Surgical treatment of small bowel neoplasms[J]. Eur Rev Med Pharmacol Sci, 2010, 14(4):327-333. |
[15] | ?ZTEKIN M, YILMAZ B, A?AGüNDüZ D, et al. Overview of helicobacter pylori infection: clinical features, treatment, and nutritional aspects. diseases[J]. 2021, 9(4):66. |
[16] | GARCIA-ORTEGA D Y, REYES-GARCIA N, MARTINEZ-SAID H, et al. Radiation-induced leiomyosarcoma of the rectum after cervical cancer treatment[J]. Rev Gastroenterol Mex (Engl Ed), 2018, 83(4):465-467. |
[17] | ANDERSON N D, BABICHEV Y, FULIGNI F, et al. Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival[J]. Nat Commun, 2021, 12(1):4496. |
[18] | Cancer Genome Atlas Research Network. Electronic address: elizabeth.demicco@sinaihealthsystem.ca; Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas[J]. Cell, 2017, 171(4):950-965.e28. |
[19] | COPE B M, TRAWEEK R S, LAZCANO R, et al. Targe-ting the molecular and immunologic features of leiomyosarcoma[J]. Cancers (Basel), 2023, 15(7):2099. |
[20] | HILAL L, BARADA K, MUKHERJI D, et al. Gastrointestinal (GI) leiomyosarcoma (LMS) case series and review on diagnosis, management, and prognosis[J]. Med Oncol, 2016, 33(2):20. |
[21] | YANG J. Primary leiomyosarcoma in the colon: A case report[J]. Medicine (Baltimore), 2018, 97(7):e9923. |
[22] | YAHAGI M, ISHII Y, HARA A, et al. Laparoscopic surgery to treat leiomyosarcomas of the sigmoid colon:a case report and literature review[J]. Surg Case Rep, 2019, 5(1):20. |
[24] | FENTY M, SHAHBAZOV R, DHIR M. Primary gastric leiomyosarcoma-a rarely encountered clinical entity[J]. J Gastrointest Surg, 2021, 25(5):1340-1342. |
[25] | SATO T, AKAHOSHI K, TOMOEDA N, et al. Leiomyosarcoma of the stomach treated by endoscopic submucosal dissection[J]. Clin J Gastroenterol, 2018, 11(4):291-296. |
[26] | SMRKE A, BENSON C, STRAUSS D C, et al. Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatments[J]. Eur J Surg Oncol, 2021, 47(10):2595-2601. |
/
〈 |
|
〉 |